{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-008395","form_type":"8-K","ticker":"OCEA","cik":"0001869974","company_name":"Ocean Biomedical, Inc.","filed_at":"2025-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.426219+00:00","generated_at":"2026-05-26T03:57:33.396840+00:00","sec_items":["3.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ocean Biomedical issues up to 45,000 Series A convertible preferred shares at $0.01 for reverse split vote","bullets":["45,000 shares of Series A preferred issued at $0.01/share; convertible into common at $0.01/share after stockholder approval of reverse split.","Holders get 2,000 votes per share solely on the reverse stock split proposal; agree to vote in same proportion as common holders.","Redemption right arises after authorized share increase approval or 90 days from closing, until 120 days after closing.","Net proceeds used for general corporate purposes if shares not redeemed or converted; total potential raise is $450.","Issuance exempt from registration under Section 4(a)(2) and Regulation D."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-008395","json":"https://secwatch.observer/filing/0001493152-25-008395.json","markdown":"https://secwatch.observer/filing/0001493152-25-008395.md","text":"https://secwatch.observer/filing/0001493152-25-008395.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1869974/000149315225008395/0001493152-25-008395-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1869974/000149315225008395/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T03:57:33.396840+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f624d86e0e3981d45bbeabfd75b9260682b9aa27","claim":"Ocean Biomedical, Inc.: Filed amendment to Certificate of Incorporation to create a series of preferred stock via Certificate of Designation (effective 2025-02-20).","evidence_excerpt":"On February 20, 2025, Ocean Biomedical, Inc. filed an amendment to its Certificate of Incorporation to create a series of preferred stock pursuant to a Certificate of Designation.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1869974/000149315225008395/0001493152-25-008395-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-02-20"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}